Pharmacological treatment of comorbid posttraumatic stress disorder in patients with bipolar disorder
Introduction The lifetime prevalence of comorbid posttraumatic stress disorder (PTSD) in patients with bipolar disorder (BD) is approximately 20%. Guidelines for BD give adequate pharmacological treatment options when there is a ‘pure’ bipolar disorder but lack of treatment options when there is a...
Main Authors: | S. Hendriks, P. Goossens |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2022-06-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933822010306/type/journal_article |
Similar Items
-
Management of nightmares in patients with posttraumatic stress disorder: current perspectives
by: El-Solh AA
Published: (2018-11-01) -
Prevalence, comorbidities, and factors associated with prolonged grief disorder, posttraumatic stress disorder and complex posttraumatic stress disorder in refugees: a systematic review
by: Franziska Lechner-Meichsner, et al.
Published: (2024-04-01) -
Assessment of clinical depression comorbid with posttraumatic stress disorder
by: Simonović Maja, et al.
Published: (2008-01-01) -
Shared decision making in pharmacotherapy decisions, perceived by patients with bipolar disorder
by: Doris Verwijmeren, et al.
Published: (2018-10-01) -
Global perspectives on bipolar disorder treatment: in-depth comparative analysis of international guidelines for medication selection
by: Ji Hyun Park, et al.
Published: (2024-05-01)